Product Description: Ziltivekimab (COR-001) is a human anti-IL-6 monoclonal antibody that is effective in reducing serum CRP. Ziltivekimab has anti-inflammatory activity and may be used in studies of chronic systemic inflammation and cardiovascular disease associated with CKD[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Kristen L Nowak, et al. A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD. Kidney360. 2020 Dec 4;2(2):224-235.
CAS Number: 2226654-05-1
Molecular Weight: N/A
Compound Purity: 99.75
Research Area: Inflammation/Immunology; Cardiovascular Disease